Lymphohistiocytoid mesothelioma of the pleura

Pathology International

Volumn 60, Issue 8, 2010, Pages 566-574

  Kawai, Toshiaki ^a   Hiroi, Sadayuki ^a   Nakanishi, Kuniaki ^a   Takagawa, Kiyoshi ^b   Haba, Reiji ^c   Hayashi, Kazuhiko ^d   Kawachi, Kae ^e   Nozawa, Akinori ^e   Hebisawa, Akira ^f   Nakatani, Yukio ^g  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Kurobe City Hospital   (Japan)

^c KAGAWA UNIVERSITY HOSPITAL   (Japan)

^d TOTTORI UNIVERSITY   (Japan)

^e YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION   (Japan)

^g CHIBA UNIVERSITY   (Japan)

Author keywords

9p21; asbestos analysis; calretinin; FISH; immunohistochemistry; lymphohistiocytoid mesothelioma

Indexed keywords

ASBESTOS; CALRETININ; CYTOKERATIN AE1; CYTOKERATIN AE3; EPITHELIAL MEMBRANE ANTIGEN; MESSENGER RNA; VIRUS RNA; TUMOR MARKER;

ADULT; ARTICLE; BIOPSY; CASE REPORT; CAUSE OF DEATH; CHROMOSOME 9P; CHROMOSOME DELETION; EPSTEIN BARR VIRUS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG RESECTION; LYMPHOHISTIOCYTOID MESOTHELIOMA; MALE; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; ELECTRON MICROSCOPY; GENETICS; MESOTHELIOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; PLEURA TUMOR;

FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MESOTHELIOMA; MICROSCOPY, ELECTRON; MIDDLE AGED; PLEURAL NEOPLASMS; RNA, VIRAL; TUMOR MARKERS, BIOLOGICAL;

EID: 77954508225     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2010.02560.x     Document Type: Article

References (29)

1. Henderson DW, Attwood HD, Constance TJ, Shilkin KB, Steele RH. Lymphohistiocytoid mesothelioma: A rare lymphomatoid variant of predominantly sarcomatoid mesothelioma. Ultrast Pathol 1988 12 : 367 384.
2. Khalidi HS, Medeiros LJ, Battifora H. Lymphohistiocytoid mesothelioma. An often misdiagnosed variant of sarcomatoid malignant mesothelioma. Am J Clin Pathol 2000 113 : 649 654.
3. Yao DX, Shia J, Erlandson RA, Klimstra DS. Lymphohistiocytoid mesothelioma: A clinical, immunohistochemical and ultrastructural study of four cases and literature review. Ultrast Pathol 2004 28 : 213 228.
4. Galateau-Salle F, Attanoos R, Gibbs AR et al. Lymphohistiocytoid variant of malignant mesothelioma of the pleura: A series of 22 cases. Am J Surg Pathol 2007 31 : 711 716.
5. Kumaki F, Kawai T, Hiroi S et al. Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas. Hum Pathol 2001 32 : 188 195.
6. Kawai T, Hiroi S, Nakanishi K, Meeker AK. Telomere length and telomerase expression in atypical adenomatous hyperplasia and small bronchioloalveolar carcinoma of the lung. Am J Clin Pathol 2007 127 : 254 262.
7. Kieff E. Epstein-Barr virus and its replication. In : Fields BNKD, Howley PM, eds. Fields Virology, 3rd edn.
8. Smith MJ, Naylor B. A method for extracting ferruginous bodies from sputum and pulmonary tissue. Am J Clin Pathol 1972 58 : 250 254.
9. Ministry of Health, Labour and Welfare. Vital Statistics of Japan 2009.
10. Robinson BW, Lake RA. Advances in malignant mesothelioma. New Engl J Med 2005 353 : 1591 1603.
11. Travis WEB, Müller-Hermelink H, Harris C. Pathology and genetics, Tumours of the lung, pleura, thymus and heart. The World Health Organization (WHO) Classification of Tumours.
12. Attanoos RL, Galateau-Salle F, Gibbs AR, Muller S, Ghandour F, Dojcinov SD. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma. Histopathol 2002 41 : 42 9.
13. Dorfmüller P, Krismann M, Müller KM. Mesotheliome mit leukoyztärem infiltat. Pathologe 2004 25 : 349 355.
14. Efremidis AP, Waxman JS, Chahinian AP. Association of lymphocytic neoplasia and mesothelioma. Cancer 1985 55 : 1056 1059.
15. Kang K, Sera Y, Okochi T, Yamamura Y. T lymphocytes in asbestosis. New Engl J Med 1974 291 : 735 736.
16. Kagan E, Solomon A, Cochrane JC et al. Immunological studies of patients with asbestosis. I. Studies of cell-mediated immunity. Clin Exp Immunol 1977 28 : 261 267.
17. Kagan E, Solomon A, Cochrane JC, Kuba P, Rocks PH, Webster I. Immunological studies of patients with asbestosis. II, Studies of circulating lymphoid cell numbers and humoral immunity. Clin Exp Immunol 1977 28 : 268 275.
18. Tondini M, Rocco G, Travaglini M, Rossi G, Buscemi A, de Fazio L. Pleural mesothelioma associated with non-Hodgkin'slymphoma. Thorax 1994 49 : 1269 1270.
19. Yu P, Fu YX. Tumor-infiltrating T. lymphocytes: Friends or foes? Lab Invest 2006 86 : 231 245.
20. Pan CC, Chen PC, Chou TY, Chiang H. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma. Hum Pathol 2003 34 : 1155 1162.
21. Cheng JQ, Jhanwar SC, Klein WM et al. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 1994 54 : 5547 5551.
22. Xio S, Li D, Vijg J, Sugarbaker DJ, Corson JM, Fletcher JA. Codeletion of p15 and p16 in primary malignant mesothelioma. Oncogene 1995 11 : 511 515.
23. Prins JB, Williamson KA, Kamp MM et al. The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma. Int J cancer 1998 75 : 649 653.
24. Illei PB, Ladanyi M, Rusch VW, Zakowski MF. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions. Cancer 2003 99 : 51 6.
25. Illei PB, Rusch VW, Zakowski MF, Ladanyi M. Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. Clin Cancer Res 2003 9 : 2108 2113.
26. Chiosea S, Krasinskas A, Cagle PT, Mitchell KA, Zander DS, Dacic S. Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas. Mod Pathol 2008 21 : 742 747.
27. Dacic S, Kothmaier H, Land S et al. Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas. Virchows Arch 2008 453 : 627 635.
28. Lipford EH, 3rd., Eggleston JC, Lillemoe KD, Sears DL, Moore GW, Baker RR. Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung. Am J Surg Pathol 1984 8 : 357 365.
29. Anraku M, Cunningham KS, Yun Z et al. Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2008 135 : 823 829.